{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:46:03Z","timestamp":1757587563319,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11845-024-03784-5","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T02:01:59Z","timestamp":1724119319000},"page":"2653-2659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gamma gap as a prognostic marker of treatment response in patients with multiple myeloma"],"prefix":"10.1007","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7655-6230","authenticated-orcid":false,"given":"Ekhlas Abdallah","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rusul Y.","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"issue":"15","key":"3784_CR1","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.3390\/ijms21155192","volume":"21","author":"HN Abramson","year":"2020","unstructured":"Abramson HN (2020) B-cell maturation antigen (BCMA) as a target for new drug development in relapsed and\/or refractory multiple myeloma. Int J Mol Sci 21(15):5192","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3784_CR2","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.3390\/ijms19113613","volume":"19","author":"M Castella","year":"2018","unstructured":"Castella M, Fern\u00e1ndez de Larrea C, Mart\u00edn-Antonio B (2018) Immunotherapy: a novel era of promising treatments for multiple myeloma. Int J Mol Sci 19(11):3613","journal-title":"Int J Mol Sci"},{"key":"3784_CR3","doi-asserted-by":"crossref","unstructured":"Sidiqi MH, Aljama M, Kumar SK et al (2020) The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied? Blood Cancer J 10(5):52","DOI":"10.1038\/s41408-020-0319-0"},{"key":"3784_CR4","doi-asserted-by":"crossref","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15(12):e538\u2013e548","DOI":"10.1016\/S1470-2045(14)70442-5"},{"issue":"7","key":"3784_CR5","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.15419\/bmrat.v9i7.754","volume":"9","author":"S Ghosal","year":"2022","unstructured":"Ghosal S, Chattopadhyaya S, Banerjee S (2022) In silico and in vitro analysis of differentially expressed microRNAs, circular RNAs, and p53 in bortezomib-resistant multiple myeloma. Biomed Res Therapy 9(7):5179\u20135190","journal-title":"Biomed Res Therapy"},{"key":"3784_CR6","doi-asserted-by":"crossref","unstructured":"Mikhael J, Ismaila N, Cheung MC et al (2019) Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline. J Clin Oncol 37(14):1228\u20131263","DOI":"10.1200\/JCO.18.02096"},{"key":"3784_CR7","unstructured":"Chung HJ, Lee W, Chun S et al (2009) Analysis of turnaround time by subdividing three phases for outpatient chemistry specimens. Ann Clin Lab Sci 39(2):144\u2013149"},{"key":"3784_CR8","doi-asserted-by":"crossref","unstructured":"Suh B, Park S, Shin DW et al (2014) Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Ann Oncol 25(11):2260\u20132266","DOI":"10.1093\/annonc\/mdu274"},{"key":"3784_CR9","doi-asserted-by":"publisher","first-page":"864","DOI":"10.29271\/jcpsp.2021.07.864","volume":"31","author":"S Zhu","year":"2021","unstructured":"Zhu S, Li W, Lin M, Li T (2021) Serum protein electrophoresis and immunofixation electrophoresis detection in multiple myeloma. J Coll Physicians Surg Pak 31:864\u2013867","journal-title":"J Coll Physicians Surg Pak"},{"key":"3784_CR10","doi-asserted-by":"crossref","unstructured":"Beaumont-Epinette MP, Moreau C, Besnard S et al (2015) Heavy\/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients. Pathol Biol (Paris) 63(4\u20135):215\u2013221","DOI":"10.1016\/j.patbio.2015.06.001"},{"key":"3784_CR11","doi-asserted-by":"crossref","unstructured":"Kumar S, Paiva B, Anderson KC et al (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 17(8):e328\u2013e346","DOI":"10.1016\/S1470-2045(16)30206-6"},{"issue":"1","key":"3784_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/leu.2008.291","volume":"23","author":"RA Kyle","year":"2009","unstructured":"Kyle RA, Rajkumar SV (2009) Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 23(1):3\u20139","journal-title":"Leukemia"},{"key":"3784_CR13","doi-asserted-by":"crossref","unstructured":"Greipp PR, Miguel JS, Durie BG et al (2005) International staging system for multiple myeloma. J Clin Oncol 23(15):3412\u20133420","DOI":"10.1200\/JCO.2005.04.242"},{"key":"3784_CR14","doi-asserted-by":"crossref","unstructured":"Turesson I, Velez R, Kristinsson SY, Landgren OLA (2010) Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic. In Mayo Clinic Proceedings (Vol. 85, No. 3, pp. 225\u2013230). Elsevier","DOI":"10.4065\/mcp.2009.0426"},{"key":"3784_CR15","doi-asserted-by":"crossref","unstructured":"Smith BD, Smith GL, Hurria A et al (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758\u20132765","DOI":"10.1200\/JCO.2008.20.8983"},{"key":"3784_CR16","doi-asserted-by":"crossref","unstructured":"Boyd KD, Ross FM, Chiecchio L et al (2011) Gender disparities in the tumor genetics and clinical outcome of multiple myeloma. Cancer Epidemiol Biomark Prev 20(8):1703\u20131707","DOI":"10.1158\/1055-9965.EPI-11-0157"},{"issue":"8","key":"3784_CR17","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/clinchem\/34.8.1633","volume":"34","author":"SN Kahn","year":"1988","unstructured":"Kahn SN, BIna M (1988) Sensitivity of immunofixation electrophoresis for detecting IgM paraproteins in serum. Clinic Chem 34(8):1633\u20131635","journal-title":"Clinic Chem"},{"issue":"7","key":"3784_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0197-1859(90)90040-F","volume":"10","author":"DF Keren","year":"1990","unstructured":"Keren DF (1990) The use of high-resolution electrophoresis, kappa and lambda quantification, and immunofixation to diagnose monoclonal gammopathies in serum. Clin Immunol Newsl 10(7):106\u2013110","journal-title":"Clin Immunol Newsl"},{"key":"3784_CR19","doi-asserted-by":"crossref","unstructured":"Potdevin F, Roncato M, Drupt F et al (1983) Immunofixation in agarose gel for the identification of monoclonal immunoglobulins. In Annales D'immunologie (Vol. 134, No. 1, pp. 105\u2013123)","DOI":"10.1016\/S0769-2625(83)80156-1"},{"key":"3784_CR20","doi-asserted-by":"crossref","unstructured":"Dupuis MM, Paul B, Loitsch G et al (2020) Gamma gap: a point-of-care test that correlates with disease burden and treatment response in multiple myeloma. JCO Oncol Practice 16(8):e751\u2013e757","DOI":"10.1200\/JOP.19.00517"},{"issue":"12","key":"3784_CR21","doi-asserted-by":"publisher","first-page":"e0143494","DOI":"10.1371\/journal.pone.0143494","volume":"10","author":"SP Juraschek","year":"2015","unstructured":"Juraschek SP, Moliterno AR, Checkley W, Miller ER III (2015) The gamma gap and all-cause mortality. PLoS ONE 10(12):e0143494","journal-title":"PLoS ONE"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03784-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-024-03784-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03784-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T12:25:39Z","timestamp":1734956739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-024-03784-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3784"],"URL":"https:\/\/doi.org\/10.1007\/s11845-024-03784-5","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Baquba Teaching Hospital Committee of Ethics and the Iraqi Ministry of Health\u2019s National Centre for Training and Human Development all permitted this study. The research was carried out in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}